메뉴 건너뛰기




Volumn 46, Issue 4, 2011, Pages 580-585

Pentostatin for treatment of steroid-refractory acute GVHD: A retrospective single-center analysis

Author keywords

acute GVHD; pentostatin; salvage treatment; steroid refractory GVHD

Indexed keywords

BASILIXIMAB; BUSULFAN; INFLIXIMAB; PENTOSTATIN; PREDNISONE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

EID: 79953679298     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.146     Document Type: Article
Times cited : (23)

References (34)
  • 4
    • 34247867901 scopus 로고    scopus 로고
    • Immunobiology of allogeneic hematopoietic stem cell transplantation
    • DOI 10.1146/annurev.immunol.25.022106.141606
    • Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 2007; 25: 139-170. (Pubitemid 46697905)
    • (2007) Annual Review of Immunology , vol.25 , pp. 139-170
    • Welniak, L.A.1    Blazar, B.R.2    Murphy, W.J.3
  • 5
    • 58149384550 scopus 로고    scopus 로고
    • Graft-versus-leukemia effects of transplantation and donor lymphocytes
    • Kolb HJ. Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 2008; 112: 4371-4383.
    • (2008) Blood , vol.112 , pp. 4371-4383
    • Kolb, H.J.1
  • 7
    • 0030861750 scopus 로고    scopus 로고
    • Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines
    • Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997; 90: 3204-3213. (Pubitemid 27444217)
    • (1997) Blood , vol.90 , Issue.8 , pp. 3204-3213
    • Hill, G.R.1    Crawford, J.M.2    Cooke, K.R.3    Brinson, Y.S.4    Pan, L.5    Ferrara, J.L.M.6
  • 8
    • 0034103630 scopus 로고    scopus 로고
    • Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets
    • Nikolic B, Lee S, Bronson RT, Grusby MJ, Sykes M. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ target. J Clin Invest 2000; 105: 1289-1298. (Pubitemid 30266082)
    • (2000) Journal of Clinical Investigation , vol.105 , Issue.9 , pp. 1289-1298
    • Nikolic, B.1    Lee, S.2    Bronson, R.T.3    Grusby, M.J.4    Sykes, M.5
  • 9
    • 39649095444 scopus 로고    scopus 로고
    • Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease
    • DOI 10.1182/blood-2006-10-049817
    • Luft T, Conzelmann M, Benner A, Rieger M, Hess M, Strohhaecker U et al. Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease. Blood 2007; 110: 4535-4542. (Pubitemid 351377821)
    • (2007) Blood , vol.110 , Issue.13 , pp. 4535-4542
    • Luft, T.1    Conzelmann, M.2    Benner, A.3    Rieger, M.4    Hess, M.5    Strohhaecker, U.6    Gorner, M.7    Hegenbart, U.8    Ho, A.D.9    Dreger, P.10
  • 10
    • 71849118213 scopus 로고    scopus 로고
    • A new approach to the blocking of alloreactive T-cell mediated graft-versus-host disease by in vivo administration of anti-CXCR3 neutralizing antibody
    • He S, Cao Q, Qiu Y, Mi J, Zhang JZ, Jin M et al. A new approach to the blocking of alloreactive T-cell mediated graft-versus-host disease by in vivo administration of anti-CXCR3 neutralizing antibody. J Immunol 2008; 181: 7581-7592.
    • (2008) J Immunol , vol.181 , pp. 7581-7592
    • He, S.1    Cao, Q.2    Qiu, Y.3    Mi, J.4    Zhang, J.Z.5    Jin, M.6
  • 11
    • 0037713989 scopus 로고
    • Pentostatin (2prime prime or minute-deoxycofor-mycin): Clinical pharmacology, role in cancer chemotherapy, and future prospects
    • Spiers AS. Pentostatin (2prime prime or minute-deoxycofor-mycin): clinical pharmacology, role in cancer chemotherapy, and future prospects. Am J Ther 1995; 2: 196-216.
    • (1995) Am J Ther , vol.2 , pp. 196-216
    • Spiers, A.S.1
  • 12
    • 79953719569 scopus 로고    scopus 로고
    • SCID: The role of adenosine deaminase deficiency
    • Resta R, Thompson LF. SCID: the role of adenosine deaminase deficiency. Immunol Today 1997; 19: 533-534.
    • (1997) Immunol Today , vol.19 , pp. 533-534
    • Resta, R.1    Thompson, L.F.2
  • 13
    • 12344281073 scopus 로고    scopus 로고
    • New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase defi-ciency
    • Hershfield MS. New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase defi-ciency. Eur J Immunol 2005; 35: 31-41.
    • (2005) Eur J Immunol , vol.35 , pp. 31-41
    • Hershfield, M.S.1
  • 14
    • 47949115543 scopus 로고    scopus 로고
    • Therapeutic benefit of pentostatin in severe IL-10?/\colitis
    • Brown JB, Lee G, Grimm GR, Barrett TA. Therapeutic benefit of pentostatin in severe IL-10?/\colitis. Inflamm Bowel Dis 2008; 14: 880-887.
    • (2008) Inflamm Bowel Dis , vol.14 , pp. 880-887
    • Brown, J.B.1    Lee, G.2    Grimm, G.R.3    Barrett, T.A.4
  • 17
    • 0023006839 scopus 로고
    • Prevention of graft-versus-host-disease in allogeneic bone marrow transplantation by pretreatment with 2'-deoxycoformycin
    • Epstein J, Bealmear PM, Kennedy DW, Herrmann MJ, Islam A, Wiedl SC. Prevention of graft-versus-host disease in allogeneic bone marrow transplantation by pretreatment with 2'-deoxycoformycin. Exp Hematol 1986; 14: 845-849. (Pubitemid 17180037)
    • (1986) Experimental Hematology , vol.14 , Issue.9 , pp. 845-849
    • Epstein, J.1    Bealmear, P.M.2    Kennedy, D.W.3
  • 19
    • 79953701839 scopus 로고    scopus 로고
    • Long-Term follow up of a phase II study of pentostatin in patients with steroid refractory acute intestinal graft-versus-host dis-ease
    • abstract 773
    • Klein S, Mousset S, Bug G, Wassmann B, Martin H. Long-Term follow up of a phase II study of pentostatin in patients with steroid refractory acute intestinal graft-versus-host dis-ease. Bone Marrow Transplant 2008; 41(Suppl 1): S222 (abstract 773).
    • (2008) Bone Marrow Transplant , vol.41 , Issue.SUPPL. 1
    • Klein, S.1    Mousset, S.2    Bug, G.3    Wassmann, B.4    Martin, H.5
  • 23
    • 27744586984 scopus 로고    scopus 로고
    • OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease
    • DOI 10.1038/sj.bmt.1705132, PII 1705132
    • Knop S, Hebart H, Gscheidle H, Holler E, Kolb HJ, Niederwieser D et al. OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease. Bone Marrow Transplant 2005; 36: 831-837. (Pubitemid 41613308)
    • (2005) Bone Marrow Transplantation , vol.36 , Issue.9 , pp. 831-837
    • Knop, S.1    Hebart, H.2    Gscheidle, H.3    Holler, E.4    Kolb, H.-J.5    Niederwieser, D.6    Einsele, H.7
  • 24
    • 34447644425 scopus 로고    scopus 로고
    • Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: A randomized multicenter trial by the EBMT Chronic Leukemia Working Party [7]
    • DOI 10.1038/sj.leu.2404731, PII 2404731
    • Knop S, Hebart H, Gratwohl A, Kliem C, Faul C, Holler E et al. Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic Leukemia Working Party. Leukemia 2009; 21: 1830-1833. (Pubitemid 47086777)
    • (2007) Leukemia , vol.21 , Issue.8 , pp. 1830-1833
    • Knop, S.1    Hebart, H.2    Gratwohl, A.3    Kliem, C.4    Faul, C.5    Holler, E.6    Apperley, J.7    Kolb, H.J.8    Schaefer, A.9    Niederwieser, D.10    Einsele, H.11
  • 26
    • 0036947659 scopus 로고    scopus 로고
    • Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation
    • DOI 10.1038/sj.bmt.1703737
    • Massenkeil G, Rackwitz S, Genvresse I, Rosen O, Dorken B, Arnold R. Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. Bone Marrow Transplant 2002; 30: 899-903. (Pubitemid 36097479)
    • (2002) Bone Marrow Transplantation , vol.30 , Issue.12 , pp. 899-903
    • Massenkeil, G.1    Rackwitz, S.2    Genvresse, I.3    Rosen, O.4    Dorken, B.5    Arnold, R.6
  • 30
    • 33645406536 scopus 로고    scopus 로고
    • The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease
    • Greinix HT, Knobler RM, Worel N, Schneider B, Schneeberger A, Hoecker P et al. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haemato-logica 2006; 91: 405-408.
    • (2006) Haemato-logica , vol.91 , pp. 405-408
    • Greinix, H.T.1    Knobler, R.M.2    Worel, N.3    Schneider, B.4    Schneeberger, A.5    Hoecker, P.6
  • 32
    • 60349129494 scopus 로고    scopus 로고
    • Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium
    • Von Bonin M, Stolzel F, Goedecke A, Richter K, Wuschek N, Holig K et al. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant 2009; 43: 245-251.
    • (2009) Bone Marrow Transplant , vol.43 , pp. 245-251
    • Von Bonin, M.1    Stolzel, F.2    Goedecke, A.3    Richter, K.4    Wuschek, N.5    Holig, K.6
  • 33
    • 77955518690 scopus 로고    scopus 로고
    • Prochymal improves response rates in patients with steroid-refractory acute graft versus host disease (SR-GVHD) involving the liver and gut: Results of a randomized, placebo-controlled, multicenter phase III trial in GVHD
    • Martin PJ, Uberti JP, Soiffer RJ, Klingemann H, Waller EK, Daly AS et al. Prochymal improves response rates in patients with steroid-refractory acute graft versus host disease (SR-GVHD) involving the liver and gut: results of a randomized, placebo-controlled, multicenter phase III trial in GVHD. Biol Blood Marrow Transplant 2010; 16(Suppl. 2): 169-170.
    • (2010) Biol Blood Marrow Transplant , vol.16 , Issue.SUPPL. 2 , pp. 169-170
    • Martin, P.J.1    Uberti, J.P.2    Soiffer, R.J.3    Klingemann, H.4    Waller, E.K.5    Daly, A.S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.